MedTrace Logo

Short Implants in Edentulous Mandible

NCT04838184 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-04-09

No results posted yet for this study

Summary

Main aim of this study was to assess survival rates of short implants with a length of 4 mm in the edentulous mandible after 1, 3, and 5 years.

Conditions

  • Tooth Loss
  • Edentulous Jaw

Interventions

DEVICE

Dental Implants (Straumann Roxolid® / SLActive®)

In this study the 4 mm implants will be inserted in the area surrounding 36/46. The implant diameters will be defined based on the patient's situation. In the interforaminal region, two implants of conventional length with a minimum of 10 mm will be inserted. The implant diameter and the length will be defined based on the patient's situation.

Sponsors & Collaborators

  • Straumann AG

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-19
Primary Completion
2024-03-31
Completion
2024-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04838184 on ClinicalTrials.gov